---
title: "Corbus Pharma (CRBP.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRBP.US/norm.md"
symbol: "CRBP.US"
name: "Corbus Pharma"
parent: "https://longbridge.com/en/quote/CRBP.US.md"
datetime: "2026-03-07T10:30:36.493Z"
locales:
  - [en](https://longbridge.com/en/quote/CRBP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRBP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRBP.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CRBP.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CRBP.US/norm.md)


# Corbus Pharma (CRBP.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.90 | -1.44 | -1.39 | -0.7825 | -1.15 |
| ROE | -91.93% | -59.34% | -50.39% | -26.03% | -39.94% |
| Revenue | - | - | - | - | - |
| Net income | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M |
| Operating income | -24.42M | -19.15M | -18.66M | -12.61M | -15.51M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 109.51M | 125.08M | 139.93M | 155.88M | 164.17M |
| Leverage | 1.19 | 1.13 | 1.10 | 1.09 | 1.09 |
| BVPS | 7.35 | 9.06 | 10.39 | 11.69 | 12.36 |
| Turnover | - | - | - | - | - |
| Cash & STI | 103.98M | 116.59M | 132.79M | 149.06M | 159.36M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 1.56M | 1.88M | 2.19M | 2.52M | 2.90M |
| Net debt | -101.93M | -114.14M | -129.93M | -145.82M | -155.75M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -15.55M | -16.60M | -16.42M | -10.94M | -13.94M |
| Investing CF | 19.64M | 17.74M | 18.12M | 8.73M | -15.37M |
| Financing CF | 2.85M | - | - | -13000.00 | 25.04M |
| Free CF | -7.30M | -10.35M | -10.77M | -8.35M | -9.11M |
| OCF coverage | - | - | - | - | -127.94% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |